AFT Pharmaceuticals - Margins improving
AFT Pharmaceuticals recently reported its H119 results. Operating revenue grew 4.1% compared to H118 and was negatively affected by the divestment...
85 Views
AFT Pharmaceuticals - Improving profitability
AFT recently announced an agreement with Baxter Healthcare to divest to Baxter some of its non-core and low-margin hospital products in New...
138 Views
AFT Pharmaceuticals - Australia and Maxigesic driving growth
AFT Pharmaceuticals is a New Zealand-based specialty pharmaceutical company that currently sells over 130 prescription specialty generics and OTC...
126 Views
On the cusp
AFT Pharma recently reported its FY17 results. Operating revenue grew 8.1% compared to FY16, mainly due to 19% growth in the Australian market,...
173 Views
Updates on several products
AFT Pharma recently made announcements affecting several of its marketed products. Importantly, the Australian Therapeutic Goods Administration...
156 Views